Enzo TBR Tablet is a combination pharmaceutical formulation containing Bromelain (180 mg), Trypsin (96 mg), and Rutoside (200 mg), designed to provide anti-inflammatory, proteolytic, and vasoprotective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, facilitates the breakdown of proteins and exhibits anti-inflammatory and analgesic properties, making it effective in reducing edema and promoting tissue repair. Trypsin, a serine protease enzyme, enhances the proteolytic activity, aiding in the degradation of necrotic tissue and fibrin deposits, thereby supporting wound healing and reducing inflammation. Rutoside, a bioflavonoid, acts as a potent antioxidant and capillary stabilizer, improving microcirculation and reducing capillary permeability, which helps in managing chronic venous insufficiency and related vascular disorders. The synergistic action of these components makes Enzo TBR Tablet suitable for adjunctive therapy in conditions characterized by inflammation, edema, and impaired microcirculation such as post-traumatic swelling, postoperative inflammation, and chronic venous diseases. It is recommended to be used under medical supervision, with dosage adjustments based on clinical response and patient tolerance. Caution is advised in patients with hypersensitivity to any component or underlying bleeding disorders.